Kaposi's sarcoma and its associated herpesvirus

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Kaposi's sarcoma (KS) is the most frequent cancer in individuals with untreated HIV infection.
• Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), is the infectious agent responsible for KS.
• Understanding KSHV's role is crucial for managing this opportunistic infection.

Purpose of the Study:

• To review the epidemiology of KS and KSHV.
• To elucidate the mechanisms by which KSHV induces KS.
• To summarize recent advancements in understanding KSHV-driven oncogenesis.

Main Methods:

• Literature review of studies on KS and KSHV epidemiology and mechanisms.
• Analysis of KSHV gene products involved in KS pathogenesis.
• Synthesis of current knowledge on viral oncogenesis.

Main Results:

• KSHV latent transcripts (e.g., LANA, viral cyclin, viral FLIP, microRNAs) promote cell proliferation and inhibit apoptosis.
• KSHV lytic proteins (e.g., viral G protein-coupled receptor, K1, viral IL-6, viral chemokines) contribute to KS lesions via paracrine neoplasia.
• These viral factors collectively drive the angioproliferative and inflammatory characteristics of KS.

Conclusions:

• KSHV employs a multi-faceted strategy involving both latent and lytic gene products to induce KS.
• The interplay of viral proteins disrupts normal cellular processes, leading to tumor formation.
• Further research into these mechanisms can inform therapeutic strategies against KS.